Free Trial

BioStem Technologies (OTCMKTS:BSEM) Trading Up 0.8% - Here's Why

BioStem Technologies logo with Medical background

Shares of BioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) were up 0.8% on Wednesday . The stock traded as high as $13.67 and last traded at $13.66. Approximately 28,914 shares traded hands during trading, a decline of 39% from the average daily volume of 47,156 shares. The stock had previously closed at $13.55.

BioStem Technologies Trading Up 0.9%

The firm has a 50-day moving average of $13.11 and a two-hundred day moving average of $13.16. The firm has a market capitalization of $225.45 million, a P/E ratio of 9.10 and a beta of -0.32.

BioStem Technologies (OTCMKTS:BSEM - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $1.25 by ($1.08). The firm had revenue of $72.53 million for the quarter, compared to analysts' expectations of $101.20 million. On average, sell-side analysts anticipate that BioStem Technologies, Inc. will post 1.41 EPS for the current fiscal year.

About BioStem Technologies

(Get Free Report)

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.

Further Reading

Should You Invest $1,000 in BioStem Technologies Right Now?

Before you consider BioStem Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioStem Technologies wasn't on the list.

While BioStem Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines